Business
Voyageur Pharmaceuticals Strengthens Leadership Team with Strategic Appointment of Dr. Ibrahim Hashmi as VP of Business Development
(TheNewswire) Calgary, Alberta, Canada – TheNewswire - September 24, 2024 - ...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals Strengthens Leadership Team with Strategic Appointment of Dr. Ibrahim Hashmi as VP of Business Development\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta, Canada –\n \n\n TheNewswire -\n \n\n September 24, 2024 -\nVoyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF)\n(\"Voyageur\" or the \"Company\") is pleased to\nannounce the appointment of Dr. Ibrahim Hashmi as Vice President of\nBusiness Development, as key strategic move that signals the\ncompany’s commitment to accelerating its commercial initiatives and\nexpanding its global footprint in the medical imaging industry.\n \n\n\n\n Dr. Hashmi brings a wealth of expertise to Voyageur,\nwith more than 25 years of experience in leading high-performance\nbusiness and medical teams across global markets, including Asia\nPacific, the Middle East, Africa, and Central Asia. His extensive\nleadership experience with multinational corporations, including his\nroles at GE Healthcare and Amersham health, positions him as a\ncritical asset in Voyageur’s mission to drive strategic market\nexpansion and secure a competitive edge in the rapidly evolving\nmedical imaging and healthcare landscape.\n \n\n\n\n Throughout his career, Dr. Hashmi has been instrumental\nin executing large scale business strategies, fostering strategic\npartnerships and driving operational excellence. His roles as\nCommercial Head at GE Healthcare for the Middle East, Africa, Central\nAsia, and Turkey, along with his most recent position as Head of\nMarketing and Commercial GM for Asia Pacific and ASEAN at GE\nHealthcare, demonstrate his ability to spearhead business development\ninitiatives in complex multinational environments.\n \n\n\n\n “Dr. Hashmi’s appointment marks a pivotal moment\nfor Voyageur as we embark on our journey to establish a stronger\npresence in the global medical imaging industry.\" said Brent\nWillis, CEO of Voyageur Pharmaceuticals. \"\n \n\n His proven ability to develop successful commercial\nstrategies and drive growth will be instrumental as we work to expand\nour product portfolio, cultivate strategic partnerships, and establish\na stronger foothold in international markets.\"\n \n\n\n\n Dr. Hashmi’s leadership will be key to advancing\nVoyageur’s strategic pr...